Richard J. Battafarano

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer

Patrick M. Forde, Jamie E. Chaft, Kellie N. Smith et al. · New England Journal of Medicine · 2018 · 2.1K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)

Tricia R. Cottrell, Elizabeth D. Thompson, Patrick M. Forde et al. · Annals of Oncology · 2018 · 589 citations · Full text

Medicine, Immunology, Oncology +17

Epigenetic therapy inhibits metastases by disrupting premetastatic niches

Zhihao Lü, Jianling Zou, Shuang Li et al. · Nature · 2020 · 337 citations · Full text

Medicine, Cancer Biology, Oncology +14

Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non–small cell lung cancer

Matthew J. Bott, Stephen C. Yang, Bernard J. Park et al. · Journal of Thoracic and Cardiovascular Surgery · 2018 · 302 citations · Full text

Medicine, Oncology, Surgery +16

Curcumin Induces Cell Death in Esophageal Cancer Cells through Modulating Notch Signaling

Dharmalingam Subramaniam, Sivapriya Ponnurangam, Prabhu Ramamoorthy et al. · PLoS ONE · 2012 · 232 citations · Full text

Life Sciences, Cell Biology, Oncology +17